Kamunting Street Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-75,000
| Closed | -$117K | – | 32 |
|
|
2022
Q3 | $117K | Buy |
+75,000
| New | +$117K | 0.19% | 21 |
|
|
2022
Q1 | – | Sell |
-64,539
| Closed | -$189K | – | 48 |
|
|
2021
Q4 | $189K | Buy |
+64,539
| New | +$189K | 0.14% | 27 |
|
|
2021
Q3 | – | Hold |
0
| – | -$275K | – | 75 |
|
|
2021
Q2 | – | Sell |
-42,594
| Closed | -$192K | – | 56 |
|
|
2021
Q1 | $192K | Sell |
42,594
-1,239
| -3% | -$5.59K | 0.08% | 69 |
|
|
2020
Q4 | $216K | Sell |
43,833
-56,167
| -56% | -$277K | 0.11% | 71 |
|
|
2020
Q3 | $593K | Buy |
+100,000
| New | +$593K | 0.37% | 28 |
|